DOI QR코드

DOI QR Code

Update knowledge on cervical cancer incidence and prevalence in Asia

  • Daniyal, Muhammad (Faculty of Eastern Medicine and Surgery, Hamdard University) ;
  • Akhtar, Naheed (College of Allied Health Professionals, Directorate of Medical Sciences, Government College University Faisalabad) ;
  • Ahmad, Saeed (Department of Pharmacy, Faculty of Pharmacy and Alternative Medicine, The Islamia University of Bahawalpur) ;
  • Fatima, Urooj (Faculty of Eastern Medicine and Surgery, Hamdard University) ;
  • Akram, Muhammad (Department of Eastern Medicine and Surgery, Faculty of Medical and Health Sciences, The University of Poonch) ;
  • Asif, Hafiz Muhammad (Department of Eastern Medicine and Surgery, Faculty of Medical and Health Sciences, The University of Poonch)
  • Published : 2015.05.18

Abstract

Cervical cancer is the second most common cause of cancer-related death among women worldwide, with over 500,000 new cases diagnosed annually and 50% mortality rate in Asia. In the United States, approximately 10,370 new cases of cervical cancer are diagnosed annually, and estimated 3,710 deaths occur from the disease, making it the sixth most common cause of malignancy among American women. This study aims to provide awareness about cervical cancer as well as an updated knowledge about the prevalence and incidence of cervical cancer in Asia.

Keywords

Cervical cancer;epidemiology;literature review;worldwide prevalence;prevalence in Asia

References

  1. Ortashi O, Raheel H, Shalal M et al (2013). Awareness and knowledge about human papillomavirus infection and vaccination among women in UAE. Asian Pac J Cancer Prev, 14, 6077-80. https://doi.org/10.7314/APJCP.2013.14.10.6077
  2. Ozkahraman S, Yildirim B (2012). Knowledge levels of Turkish nurses related to prevention and early diagnosis of cancer. Asian Pac J Cancer Prev, 13, 6105-8. https://doi.org/10.7314/APJCP.2012.13.12.6105
  3. Parkin DM, Bray F, Ferlay J, et al., (2005). Global cancer statistic. CA Cancer J Clin, 55, 74-8. https://doi.org/10.3322/canjclin.55.2.74
  4. Pandey S, Mishra M (2012). Human papilloma virus screening in North Indian Women. Asian Pac J Cancer Prev, 13, 2643-46 https://doi.org/10.7314/APJCP.2012.13.6.2643
  5. Pradhananga KK, Baral M, Shrestha BM (2009). Multi-institution hospital-based cancer incidence data for Nepal: an initial report. Asian Pac J Cancer Prev, 10, 259-62.
  6. Qasem MB (2001). Cancer registration in Jordan. Asian Pac J Cancer Prev, 2, 37-8.
  7. Rai AK, Das D, Kataki AC, et al (2014). Hybrid capture 2 assay based evaluation of high-risk HPV status in healthy women of north-east India. Asian Pac J Cancer Prev, 15, 861-5 https://doi.org/10.7314/APJCP.2014.15.2.861
  8. Makoha FW, Raheem MA (2008). Gynecological cancer incidence in a hospital population in Saudi Arabia: the effect of foreign immigration over two decades. J Obstet Gynaecol Res, 34, 538-42. https://doi.org/10.1111/j.1447-0756.2008.00735.x
  9. Moosa NY, Khattak N, Alam MI, et al (2014). Comparison of cervical cell morphology using two different cytology techniques for early detection of pre-cancerous lesions. Asian Pac J Cancer Prev, 15, 975-81. https://doi.org/10.7314/APJCP.2014.15.2.975
  10. Nandakumar A, Ramnath T, Meesha C (2009). Magnitude of cancer cervix in India. Indian J Med Res, 130, 219-21.
  11. Natphopsuk S, Settheetham-Ishida W, Pientong C, et al (2013). Human papillomavirus genotypes and cervical cancer in northeast Thailand. Asian Pac J Cancer Prev, 14, 6961-4. https://doi.org/10.7314/APJCP.2013.14.11.6961
  12. McDougall JA, Madeleine M (2003). Racial and ethnic disparities in cervical cancer incidence rates in the United States, 1992-2003. Cancer Causes Control, 8, 1175-86.
  13. Zhou X, Gu Y, Zhang SL (2012). Association between p53 codon 72 polymorphism and cervical cancer risk among Asians: a HuGE review and meta-analysis. Asian Pac J Cancer Prev, 13, 4909-14. https://doi.org/10.7314/APJCP.2012.13.10.4909
  14. Rosemawati A, Sallehudin AB (2001). Cancer registration in Malaysia. Asian Pac J Cancer Prev, 2, 43-5.
  15. Sarjadi, Trihartani P (2001). Cancer registration in Indonesia. Asian Pac J Cancer Prev, 2, 21-4.
  16. Schoueri-Mychasiw N, McDonald PW (2013). Factors Associated with Underscreening for Cervical Cancer among Women in Canada. Asian Pac J Cancer Prev, 14, 6445-50. https://doi.org/10.7314/APJCP.2013.14.11.6445
  17. Shin HR, Lee DH, Herrero R, et al (2003). Prevalence of human papillomavirus infection in women in Busan, South Korea. Int J Cancer, 103, 413-21. https://doi.org/10.1002/ijc.10825
  18. Siegel R, Brawley O, Jemal A (2011). Cancer statistics, 2011: the impact of eliminating socioeconomic and racial disparities on premature cancer deaths. CA Cancer J Clin, 212-36.
  19. Sukvirach S, Smith JS, Tunsakul S, et al (2003). Populationbased human papillomavirus prevalence in Lampang and Songkla, Thailand. J Infect Dis, 187, 1246-56. https://doi.org/10.1086/373901
  20. Tas F, Isler A, Esenay F (2010). Awareness of Turkish nursing students about risk factors for cervical cancer and prophylactic human papillomavirus vaccine. Sex Disabil, 28, 245-53. https://doi.org/10.1007/s11195-010-9172-6
  21. Tewari KS, Monk BJ (2012). Invasive cervical cancer. In: DiSaia P, Creasman W (eds) Clinical Gynecologic Oncology, 8th edn. Philadelphia, PA: Elsevier, 24-28.
  22. Tezcan S, Ozgur D, Ulger M, et al (2014). Human papillomavirus genotype distribution and E6/ E7 oncogene expression in Turkish women with cervical cytological findings. Asian Pac J Cancer Prev, 15, 3997-4003 https://doi.org/10.7314/APJCP.2014.15.9.3997
  23. Tungsrithong N, Kasinpila C, Maneenin C, et al (2014). Lack of significant effects of Chlamydia trachomatis infection on cervical cancer risk in a nested case-control study in North-East Thailand. Asian Pac J Cancer Prev, 15, 1497-500. https://doi.org/10.7314/APJCP.2014.15.3.1497
  24. Wang YY, Li L, Wei S et al (2013). Human papillomavirus (HPV) infection in women participating in cervical cancer screening from 2006 to 2010 in Shenzhen City, South China. Asian Pac J Cancer Prev, 14, 7483-7. https://doi.org/10.7314/APJCP.2013.14.12.7483
  25. Wang JL, Yang YZ, Dong WW, et al (2013). Application of human papillomavirus in screening for cervical cancer and precancerous lesions. Asian Pac J Cancer Prev, 14, 2979-82. https://doi.org/10.7314/APJCP.2013.14.5.2979
  26. Wang Q (2001). Cancer registration in China. Asian Pac J Cancer Prev, 2, 3-8.
  27. Zechariah A, Hassan S, Samuel K, et al (2014). Nurses role in cervical cancer prevention and its treatment- A critical review. Asian Pac J Nurs, 1, 1-5. https://doi.org/10.4103/2347-5625.135799
  28. Zhao FH, Tiggelaar SM, Hu SY, et al (2012). A multi-center survey of HPV knowledge and attitudes toward HPV vaccination among women, government officials, and medical personnel in China. Asian Pac J Cancer Prev, 13, 2369-78. https://doi.org/10.7314/APJCP.2012.13.5.2369
  29. Raychaudhuri S, Mandal S (2012). Current status of knowledge, attitude and practice (KAP) and screening for cervical cancer in countries at different levels of development. Asian Pac J Cancer Prev, 13, 4221-7. https://doi.org/10.7314/APJCP.2012.13.9.4221
  30. AAntic LG, Djikanovic BS, Antic DZ, et al (2014). Differencies in the level of knowledge on cervical cancer among health care students, midwives and patients in Serbia. Asian Pac J Cancer Prev, 15, 3011-5. https://doi.org/10.7314/APJCP.2014.15.7.3011
  31. Ahn Y-O (2001). Population-based cancer registries in Korea. Asian Pac J Cancer Prev, 2, 39-42.
  32. Al Hamdan N, Bazarbashi S, Ajarim D, et al (2001). Cancer 799. registration in Saudi Arabia. Asian Pac J Cancer Prev, 2, 61-4.
  33. Al-Naggar RA, Isa ZM (2010). Perception and opinion of medical students about Pap smear test: a qualitative study. Asian Pac J Cancer Prev, 11, 435-40.
  34. Arab M, Giti Noghabaei G, Kazemi SN (2014). Comparison of crude and age-specific incidence rates of breast, ovary, endometrium and cervix cancers in Iran, 2005. Asian Pac J Cancer Prev, 15, 2461-4 https://doi.org/10.7314/APJCP.2014.15.6.2461
  35. Arbyn M, Castellsague X, de Sanjose S, et al (2011). Worldwide burden of cervical cancer in 2008. Ann Oncol, 22, 2675-86. https://doi.org/10.1093/annonc/mdr015
  36. Beiki O, Hall P, Ekbom A, Moradi T (2012). Breast cancer incidence and case fatality among 4.7 million women in relation to social and ethnic background: a population-based cohort study. Breast Cancer Res, 14, 5.
  37. Berraho M, Bendahhou K, Obtel M, et al (2012). Cervical cancer in Morocco: epidemiological profile from two main oncological centers. Asian Pac J Cancer Prev, 13, 3153-7. https://doi.org/10.7314/APJCP.2012.13.7.3153
  38. Chen Q, Luo ZY, Lin M, et al (2012). Prevalence and genotype distribution of human papillomavirus infections in women attending hospitals in Chaozhou of Guangdong province. Asian Pac J Cancer Prev, 13, 1519-24. https://doi.org/10.7314/APJCP.2012.13.4.1519
  39. Deerasamee S, Martin N, Sontipong S, et al (2001). Cancer 750. registration in Thailand. Asian Pac J Cancer Prev, 2, 79-84.
  40. Demirtas B, Acikgoz I (2013). Promoting attendance at cervical cancer screening: understanding the relationship with Turkish womens' health beliefs. Asian Pac J Cancer Prev, 14, 333-40. https://doi.org/10.7314/APJCP.2013.14.1.333
  41. Esteban DB, Laudico AV, Uy N (2001). Cancer 768. registration in the Philippines. Asian Pac J Cancer Prev, 2, 55-60.
  42. Farhath S, Vijaya PP, Mumtaj P (2013). Cervical cancer: is vaccination necessary in India? Asian Pac J Cancer Prev, 14, 2681-4. https://doi.org/10.7314/APJCP.2013.14.4.2681
  43. Ferlay J, Shine HR, Bray F, et al (2010). Estimates of worldwide burden of cancer in 2008: GLOBOCAN. Int J Cancer, 127, 2893-917. https://doi.org/10.1002/ijc.25516
  44. Filipi K, Xhani A (2014). Assessment of cervical cytological data in Albanian females. Asian Pac J Cancer Prev, 15, 2129-32. https://doi.org/10.7314/APJCP.2014.15.5.2129
  45. Foley G, Alston R, Geraci M, et al (2011). Incresing rates of Cervical Cancer in young women in England. Br J Cancer, 105, 177-84. https://doi.org/10.1038/bjc.2011.196
  46. Foreman J, Foruzanfar H, Allyne M, et al (2011). Brest and cervical cancer in 187 countries between 1980 and 2010. Lancet, 378, 1461-84. https://doi.org/10.1016/S0140-6736(11)61351-2
  47. Gajalakshmi V, Shantha V, Swaminathan R (2001). Cancer registration in India. Asian Pac J Cancer Prev, 2, 13-20.
  48. Ghim S-J, Basu PS, Jenson AB (2002) Cervical cancer: etiology, pathogenesis, treatment, and future vaccines. Asian Pac J Cancer Prev, 3, 207-14.
  49. Ghojazadeh M, Azar ZF, Saleh P (2012). Knowledge and attitude of Iranian university students toward human papilloma virus. Asian Pac J Cancer Prev, 13, 6115-9. https://doi.org/10.7314/APJCP.2012.13.12.6115
  50. Giles M, Garland S (2006). A study of women's knowledge, Asian Pac J Cancer Prev, 15, 2014-83.
  51. Horner M (2011). U.S. geographical distribution of prevaccine era cervical cancer screening, incidence, stage, and mortality. Cancer Epidemol Biomarkers Prev, 20, 591-9. https://doi.org/10.1158/1055-9965.EPI-10-1183
  52. Jemal A, Murray T, Ward E, et al., (2005) Cancer statistics. CA Cancer J Clin, 55, 10-30. https://doi.org/10.3322/canjclin.55.1.10
  53. Karadag G, Gungormus Z, Surucu R (2014). Awareness and practices regarding breast and cervical cancer among Turkish women in Gazientep. Asian Pac J Cancer Prev, 15, 1093-8. https://doi.org/10.7314/APJCP.2014.15.3.1093
  54. Kaku M, Mathew A, Rajan B (2008). Impact of socio-economic factors in delayed reporting and late-stage presentation among patients with cervix cancer in a major cancer hospital in South India. Asian Pac J Cancer Prev, 9, 589-94.
  55. Karadag G, Gungormus Z, Surucu R, et al (2014). Awareness and practices regarding breast and cervical cancer among Turkish women in Gazientep. Asian Pac J Cancer Prev, 15, 1093-8. https://doi.org/10.7314/APJCP.2014.15.3.1093
  56. Li J, Huang R, Schmidt JE, et al (2013). Epidemiological features of human papillomavirus (HPV) infection among women living in Mainland China. Asian Pac J Cancer Prev, 14, 4015-23. https://doi.org/10.7314/APJCP.2013.14.7.4015

Cited by

  1. Caudatin targets TNFAIP1/NF-κB and cytochrome c/caspase signaling to suppress tumor progression in human uterine cancer vol.49, pp.4, 2016, https://doi.org/10.3892/ijo.2016.3662
  2. In Vitro and in Vivo Anticancer Activity of Sophorolipids to Human Cervical Cancer vol.181, pp.4, 2017, https://doi.org/10.1007/s12010-016-2290-6